查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466427

基因合成市场：副产品、方法、基因型、应用和最终用途 - 2024-2030 年全球预测

Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年基因合成市场规模为42.4亿美元，2024年达46.8亿美元，2030年预计将达87亿美元，复合年增长率为10.82%。

基因合成市场包括与研究、医学、农业和生物技术等各行业透过化学方法人工创建 DNA 序列相关的技术、产品和服务。典型的最终用户包括学术机构、製药和生物技术公司、政府机构和委外研发机构(CRO)。全球人口中慢性病盛行率的不断上升、对个人化药物的需求不断增加，以及基因组研究的进步正在推动这一市场的发展。此外，基因合成相对于传统方法的优势正在推动市场成长。然而，诸如规范基因改造作物开发和商业化的严格法规以及对合成基因的大小和复杂性的限制等技术挑战限制了基因合成市场的成长。提高效率和精度的基因合成新技术以及基因合成在能源和农业领域的广泛应用正在为市场创造巨大的成长机会。

主要市场统计
基准年[2023] 42.4亿美元
预测年份 [2024] 46.8亿美元
预测年份 [2030] 87亿美元
复合年增长率（%） 10.82%

扩大支持产品合成基因精确设计的软体的使用

基因合成硬件，包括寡核苷酸合成器，是合成 DNA 和 RNA 短片段（称为寡核苷酸）的专用设备。这些合成器在基因合成的早期阶段至关重要，可以创建组装成更长基因序列的构建块。基因定序仪对于此目的至关重要，它提供高通量和准确的定序能力，以确保合成基因符合预期设计。自动液体处理系统用于在移液、稀释和混合组装和扩增步骤所需的试剂和寡核苷酸期间减少错误并提高通量。基因合成服务涉及生产可自订的合成 DNA 序列，以满足特定的研究或工业要求。这些服务对于蛋白质生产、抗体工程、疫苗开发和生质燃料研究等各种应用至关重要。对自订基因的需求不断增长，导致越来越多的服务供应商提供基因合成的端到端解决方案。该软体解决方案专为合成基因设计和模拟而设计。这些工具使研究人员和生物技术人员能够透过优化密码子使用偏差、RNA 二级结构预测、GC 含量和限制性内切酶位点避免等因素来简化他们的工作流程。此外，基因合成软体可降低 DNA 从头合成过程中出现错误的风险，有助于提高研究效率并最大限度地降低成本。

方法 提高大型计划中基于晶片的合成的利用率

基于晶片的合成使用微阵列或生物晶片在小玻片上同时合成数千种寡核苷酸。这种高通量方法适用于需要多个基因的大型计划或当成本效率很重要时。基于 PCR 的酵素合成使用 DNA聚合酵素等酶，透过连续几轮的 PCR 扩增将短寡核苷酸组装成全长基因。这种方法提供快速的周转时间，非常适合专注于单一基因或基因变异的小型计划。固相合成将核苷酸依序付加固定在撑体上的不断生长的 DNA 链中。此方法保真度高，并且可以产生比其他方法错误更少的长 DNA 序列。基于晶片的综合非常适合需要成本效率的大型计划。基于 PCR 的酶合成非常适合专注于单基因或基因变异的小型计划，其中快速週转时间至关重要，而固相合成需要高保真度和长 DNA 序列时则首选。

基因型表现基因合成具有越来越大的潜力，为时间敏感的计划提供快速获取短基因的途径。

复杂基因合成专注于创建包含挑战性序列的合成基因，例如高 GC 含量、串联重复序列和同聚物区域。疫苗开发、途径工程和酵素优化等治疗应用的高级研究需要这些基因。 Express Gene Synthesis 适合需要快速週转时间进行小型计划和概念验证研究的科学家。与其他类型的基因合成相比，合成基因的长度短，传递时间短。标准基因合成使用多种技术，包括寡核苷酸组装和纠错，来合成高品质、无错误的 DNA 序列。此产品类型最常用于常规分子生物学计划，包括克隆、表达分析和重组蛋白生产。

最终用途生物技术和製药公司越来越关注创新药物发现和治疗方法开发。

学术机构和政府研究机构由于专注于基础研究、治疗开发和基因工程的进步，对基因合成市场的需求做出了重大贡献。这些研究机构使用基因合成服务来产生自订DNA 序列、设计生物途径和目标基因修饰。生物技术和製药公司严重依赖基因合成服务来推进药物发现、治疗方法开发和精准医疗。自订基因促进蛋白质表现研究、新药物标靶的鑑定以及疾病特异性动物模型的开发。受託研究机构已成为基因合成服务的重要最终用户，为生物製药和学术客户提供基因库建设、自订克隆和蛋白质表现优化方面的支援。生物技术和製药公司由于专注于创新药物发现和治疗开发而占据最大份额。学术和政府研究机构也纷纷效仿，并专注于基因工程的基础研究和进展。透过提供满足各行业不同客户需求的全面基因组学解决方案，CRO 正经历快速成长。

基因型：越来越多的机会表达针对特定宿主生物体中高水平表达而优化的基因。

复杂基因的特征是其核苷酸序列复杂，通常含有高GC含量、重复序列和容易产生二级结构的序列。这种复杂性可能会给合成过程和随后的克隆带来挑战。具有长均聚物运作或编码剪接位点的基因也可以被认为是复杂的。合成复杂的基因需要先进的技术和精心的设计，以确保最终产品的保真度和功能性。表达基因是指经优化以在特定宿主生物体中高水平表达的合成产生的DNA序列。这些基因变体通常会经历密码子优化，即更改密码子以匹配表达系统的首选用途，并导致 mRNA 更有效地翻译为蛋白质。此外，可以将强启动子、增强子和其他调控元件付加到表达的基因中，以促进研究或工业酵素应用的蛋白质生产。标准基因是合成的 DNA 序列，是基因合成服务的基本产品。该基因不具有复杂基因中的复杂性，且未针对涉及表达基因的过度表现进行最佳化。相反，标准基因为研究人员提供了一种准确、可靠且经济高效的方法来获取反映天然 DNA 序列或包含微小修饰的 DNA 序列，以用于克隆和功能分析。标准基因是许多基因工程计划的支柱，广泛应用于生命科学的各个领域。

区域洞察

由于发达的医疗保健部门和支持性政府计划的存在，美洲的基因合成市场高度发展。这是由于研发设施的改善、可支配收入的增加和经济状况的快速发展。此外，联邦机构和当局还推出了多项倡议、计划和计划，以鼓励该地区的基因治疗研究，形成美洲基因合成的平台。印度、中国、新加坡和马来西亚等新兴国家由于医疗保健标准的提高而具有市场扩张的潜力。国内基因合成製造商在这些经济体中占有重要地位，有助于大型跨国企业快速渗透市场。慢性病的流行、技术的进步和医疗基础设施的改善是推动欧洲、中东和非洲基因合成市场的关键原因。该地区各国政府继续投资基因治疗，从而扩大了各种基因合成的使用。 2022年2月，荷兰政府投资5,504万美元建造一座新的国家试点工厂，以推进有前景的细胞和基因疗法的开发和製造。荷兰政府的投资预计将为细胞和基因治疗公司提供巨大的机会。

FPNV定位矩阵

FPNV定位矩阵对于评估基因合成市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对基因合成市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1. 基因合成市场的市场规模与预测是多少？

2.在基因合成市场的预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.基因合成市场的技术趋势与法规结构是什么？

4.基因合成市场主要厂商的市场占有率是多少？

5. 进入基因合成市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界人口慢性病盛行率
      • 基因组研究活动的增加和对个人化医疗的日益关注
      • 增加私营和公共部门对药物研究的投资
    • 抑制因素
      • 基因合成的严格监管以及与该过程相关的高成本
    • 机会
      • 基因合成新技术
      • 基因合成在能源和农业产业的利用
    • 任务
      • 合成基因的大小和复杂性的限制
  • 市场区隔分析
    • 产品：扩大软体的使用范围以准确设计合成基因
    • 方式：在大型计划中增加基于晶片的综合的使用
    • 基因分型：增加快速基因合成的潜力，以便为时间敏感的计划快速获取短基因
    • 最终用途：生物技术和製药公司越来越关注创新药物发现和治疗开发
    • 基因型：为在特定宿主生物体中高水平表达而优化的表达基因的生长潜力
  • 市场趋势分析
    • 持续的技术进步加速了合成基因的生产，以及美洲地区领先公司的强大影响力
    • 亚太地区生物技术和製药领域的研发活动活跃，合成基因应用需求不断成长
    • 政府支持在欧洲、中东和非洲地区推广基因组计划和基因合成在农业的应用
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章 基因合成市场：副产品

  • 硬体
  • 服务
  • 软体

第七章 基因合成市场：依方法分类

  • 基于晶片的合成
  • 基于PCR的酶合成
  • 固相合成

第八章 基因合成市场：依基因类型

  • 复杂基因
  • 表达基因
  • 标准基因

第九章基因合成市场：依应用分类

  • 疾病诊断
  • 基因/细胞疗法的发展
  • 疫苗开发

第10章基因合成市场：依最终用途

  • 学术和政府研究机构
  • 生物技术和製药公司
  • 合约研究组织

第十一章 北美和南美基因合成市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太基因合成市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲基因合成市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Evonetix 和 Analog Devices Inc 开发创新基因合成平台
    • Gyros Protein Technologies 和 Biotage 联手透过新的自动化解决方案提高胜胜肽精製效率
    • Synprogen 和 Gingo Bioworks 宣布计划在日本加速全球 DNA 製造和基因治疗平台服务
    • Twist Bioscience 推出 Express Genes 快速基因合成服务
    • 生技公司完成 560 万英镑种子轮资金筹措
    • 布鲁克以 1.08 亿美元收购 Phenomex
    • 系列资金支持 DNA 合成技术的扩展
    • NunaBio 筹集 190 万英镑种子资金以扩大基础设施并加速研发
    • Elegen推出高速长链DNA合成仪ENFINIA DNA，促进生物经济
    • Ansa Biotechnologies 宣布成功合成新型 1005 碱基寡核苷酸
    • 金斯瑞扩大在新加坡的业务范围，提供优质基因合成服务
    • Evonetix 完成 2,400 万美元资金筹措
    • 基因合成（端到端）Barcode Biosciences 在印度启动销售
    • Eurofins Genomics Blue Heron推出IVT mRNA合成服务：基因表现的未来

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-3A2E844FEB5F

[181 Pages Report] The Gene Synthesis Market size was estimated at USD 4.24 billion in 2023 and expected to reach USD 4.68 billion in 2024, at a CAGR 10.82% to reach USD 8.70 billion by 2030.

The gene synthesis market comprises technologies, products, and services related to the artificial creation of DNA sequences through chemical methods in various industries such as research, medicine, agriculture, and biotechnology. Key end-users include academic institutions, pharmaceutical and biotechnology companies, government agencies, and contract research organizations (CROs). The growing prevalence of chronic conditions among the global population and rising demand for personalized medicines, along with advancements in genomics research, are driving this market. Moreover, the advantage of gene synthesis over traditional methods is fueling market growth. However, strict regulations governing the development and commercialization of GMOs and technical challenges such as limitations in size and complexity of synthetic genes limit the growth of the gene synthesis market. Emerging technologies in gene synthesis for efficiency and accuracy and the growing utilization of gene synthesis in energy and agriculture industries are creating significant growth opportunities in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 4.24 billion
Estimated Year [2024] USD 4.68 billion
Forecast Year [2030] USD 8.70 billion
CAGR (%) 10.82%

Product: Expanding usage of software that helps design synthetic genes accurately

Gene synthesis hardware, including oligonucleotide synthesizers, are specialized instruments used for the synthesis of short DNA or RNA fragments called oligonucleotides. These synthesizers are essential in the initial steps of gene synthesis, creating the building blocks that will be assembled into longer gene sequences. Gene sequencers are critical for this purpose, providing high-throughput and accurate sequencing capabilities to ensure the synthetic genes match the intended design. Automated liquid handling systems are employed to reduce errors and increase throughput during the pipetting, dilution, and mixing of reagents and oligonucleotides necessary for assembly and amplification steps. Gene synthesis services involve the production of synthetic DNA sequences that can be customized to cater to specific research or industrial requirements. These services are essential for various applications such as protein production, antibody engineering, vaccine development, and biofuel research. The growing demand for custom-made genes has led to an increase in service providers offering end-to-end solutions in gene synthesis. Software solutions are designed specifically for designing and simulating synthetic genes. These tools allow researchers and biotechnologists to streamline their workflow by optimizing factors such as codon usage bias, RNA secondary structure prediction, GC content, and restriction enzyme site avoidance. Moreover, gene synthesis software helps reduce the risk of errors during de novo DNA synthesis, thereby improving research efficiency and minimizing costs.

Method: Rising utilization of chip-based synthesis for large-scale projects

Chip-based synthesis uses microarrays or biochips to synthesize thousands of oligonucleotides simultaneously on a small glass slide. This high-throughput method is suitable for large-scale projects requiring multiple genes or when cost-efficiency is crucial. PCR-based enzyme synthesis involves using enzymes such as DNA polymerase to assemble short overlapping oligonucleotides into full-length genes through consecutive rounds of PCR amplification. This method offers quick turnaround times and is ideal for small-scale projects focusing on single genes or gene variants. Solid-phase synthesis involves sequentially adding nucleotides to a growing DNA chain immobilized on a solid support. This method offers high fidelity and can generate long DNA sequences with fewer errors than other methods. Chip-based synthesis is best suited for large-scale projects requiring cost efficiency. PCR-based enzyme synthesis is ideal when rapid turnaround times are essential for small-scale projects focusing on single genes or gene variants, while solid-phase synthesis is preferred when high fidelity and longer DNA sequences are required.

Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects

Complex gene synthesis focuses on creating synthetic genes that contain challenging sequences, such as high GC content, tandem repeats, and homopolymeric regions. Scientists often require these genes for advanced research in therapeutic applications such as vaccine development, pathway engineering, and enzymatic optimization. Express gene synthesis caters to scientists who require fast turnaround times for small-scale projects or proof-of-concept studies. These synthesized genes are shorter in length and have a quicker turnaround time compared to other types of gene synthesis. Standard gene synthesis involves the synthesis of high-quality, error-free DNA sequences using a variety of techniques, including oligonucleotide assembly and error correction. This type is most commonly used in routine molecular biology projects involving cloning, expression analysis, and recombinant protein production.

End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies

Academic and government research institutes significantly contribute to gene synthesis market demand because they focus on basic research, therapeutic development, and genetic engineering advancements. These institutes utilize gene synthesis services to generate custom DNA sequences, design biological pathways, and perform targeted gene modifications. Biotechnology and pharmaceutical companies rely heavily on gene synthesis services for drug discovery, therapeutic development, and precision medicine advancements. Custom genes facilitate protein expression studies, identification of novel drug targets, and development of disease-specific animal models. Contract research organizations have emerged as vital end-users of gene synthesis services, supporting biopharmaceutical and academic clients in gene library construction, custom cloning, and protein expression optimization. Biotechnology and pharmaceutical companies command the largest share due to their focus on innovative drug discovery and therapeutic development. Academic government research institutes follow closely, emphasizing fundamental research and genetic engineering advancements. CROs are experiencing rapid growth by offering comprehensive genomics solutions that cater to diverse client demands across industries.

Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms

Complex genes are characterized by their intricate nucleotide sequences, which often include high GC content, repeated sequences, or sequences prone to secondary structures. Such complexities can pose challenges during the synthesis process and subsequent cloning. Genes with long homopolymeric runs or cryptic splice sites are also considered complex. Synthesizing complex genes requires advanced techniques and careful design to ensure the fidelity and functionality of the final product. Express genes refer to synthetically manufactured DNA sequences optimized for high levels of expression in specific host organisms. These gene variants usually undergo codon optimization, where codons are modified to match the preferred usage of the expression system, leading to more efficient translation of the mRNA into proteins. Additionally, express genes can be outfitted with strong promoters, enhancers, and other regulatory elements to boost protein production for research or industrial enzyme applications. Standard genes are synthetic DNA sequences that represent the basic offering in gene synthesis services. The genes do not possess the complexities found in complex genes and are not optimized for overexpression, including express genes. Instead, standard genes provide researchers with accurate, reliable, and cost-effective means to obtain DNA sequences that are reflective of the native DNA sequence or include slight modifications for cloning or functional analysis. Standard genes are the backbone of many genetic engineering projects and are widely used across different domains of life sciences.

Regional Insights

The gene synthesis market in the Americas is highly developing owing to the presence of a developed healthcare sector and supportive government programs, which has resulted in considerable product development and the commercialization of gene synthesis technologies in the United States and Canada. This is attributed to growing improvements in R&D facilities, available disposable income, and rapidly developing economic conditions. Moreover, federal agencies and authorities have launched several initiatives, programs, and schemes to encourage gene therapy research in the region, creating a platform for gene synthesis in the Americas. Emerging economies such as India, China, Singapore, and Malaysia are potential markets for market expansion due to improved healthcare standards. These economies have a considerable presence of domestic manufacturers of gene synthesis, which contributes to an upsurge in the market penetration of multinational giants. The growing prevalence of chronic diseases, increasing technological advancements, and improved healthcare infrastructure are the primary reasons driving the gene synthesis market in EMEA. Governments across the region have been continuously investing in gene therapies, thereby expanding the utilization of various gene syntheses. In February 2022, the Dutch government invested USD 55.04 million to build a new national pilot factory to advance the development and manufacturing of promising cell and gene therapies. The investment by the Dutch government is expected to provide excellent opportunities for cell and gene therapy companies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Gene Synthesis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Synthesis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Synthesis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Ansa Biotechnologies, Inc., Applied Biological Materials Inc., AstraZeneca PLC, Azenta, Inc., Barcode Biosciences Private Limited, BGI Genomics by BGI Group, BioCat GmbH by AddLife AB, Biomatik Corporation, Bioneer Corporation, Biotage AB, Biotech Desk Pvt. Ltd., Boster Biological Technology, Brooks Automation Inc., Camena Bioscience, Charles River Laboratories International, Inc., Constructive Bio Ltd, Creative Biogene, Danaher Corporation, DNA TwoPointO Inc., Elabscience Biotechnology Inc., Elegen Corp., Eurofins Scientific SE, Evonetix Ltd., GenCefe Biotech Limited, Gene Universal, Inc., General Biosystems, Inc., GenScript Biotech Corporation, Ginkgo Bioworks Holdings, Inc., Macrogen, Inc., Merck KGaA, NZYTech, Lda., OriGene Technologies, Inc., ProMab Biotechnologies, Inc., ProteoGenix SAS, QIAGEN N.V., Synbio Technologies LLC, Telesis Bio Inc., Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Hardware
    • Services
      • Antibody DNA Synthesis
      • Viral DNA Synthesis
    • Software
  • Method
    • Chip-Based Synthesis
    • PCR-Based Enzyme Synthesis
    • Solid-Phase Synthesis
  • Gene Type
    • Complex Gene
    • Express Gene
    • Standard Gene
  • Application
    • Disease Diagnosis
    • Gene & Cell Therapy Development
    • Vaccine Development
  • End-use
    • Academic & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Gene Synthesis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Synthesis Market?

3. What are the technology trends and regulatory frameworks in the Gene Synthesis Market?

4. What is the market share of the leading vendors in the Gene Synthesis Market?

5. Which modes and strategic moves are suitable for entering the Gene Synthesis Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic conditions among the global population
      • 5.1.1.2. Increasing genomics research activities and rising focus on personalized medicines
      • 5.1.1.3. Growing investments by the private and public sectors in pharmaceutical research
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulations governing gene synthesis and high cost associated with the process
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging new technologies in gene synthesis
      • 5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in size and complexity of synthetic genes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Expanding usage of software that helps design synthetic genes accurately
    • 5.2.2. Method: Rising utilization of chip-based synthesis for large-scale projects
    • 5.2.3. Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
    • 5.2.4. End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
    • 5.2.5. Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms
  • 5.3. Market Trend Analysis
    • 5.3.1. Ongoing technological advancements to increase the speed of synthetic gene production coupled with a strong foothold of major players in the Americas region
    • 5.3.2. Robust R&D activities in biotechnology and pharmaceutical sectors and the rising need for synthetic gene applications in the Asia-Pacific
    • 5.3.3. Supportive government initiatives for genomic projects and advancing use of gene synthesis in agricultural sector in EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Gene Synthesis Market, by Product

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Services
  • 6.4. Software

7. Gene Synthesis Market, by Method

  • 7.1. Introduction
  • 7.2. Chip-Based Synthesis
  • 7.3. PCR-Based Enzyme Synthesis
  • 7.4. Solid-Phase Synthesis

8. Gene Synthesis Market, by Gene Type

  • 8.1. Introduction
  • 8.2. Complex Gene
  • 8.3. Express Gene
  • 8.4. Standard Gene

9. Gene Synthesis Market, by Application

  • 9.1. Introduction
  • 9.2. Disease Diagnosis
  • 9.3. Gene & Cell Therapy Development
  • 9.4. Vaccine Development

10. Gene Synthesis Market, by End-use

  • 10.1. Introduction
  • 10.2. Academic & Government Research Institutes
  • 10.3. Biotechnology & Pharmaceutical Companies
  • 10.4. Contract Research Organizations

11. Americas Gene Synthesis Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Gene Synthesis Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Gene Synthesis Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Evonetix and Analog Devices Inc To Progress Revolutionary Gene Synthesis Platform
    • 14.3.2. Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency With New Automated Solution
    • 14.3.3. Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan
    • 14.3.4. Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
    • 14.3.5. Biotech Firm Closes GBP 5.6 million Seed Financing
    • 14.3.6. Bruker to Buy PhenomeX For USD 108 Million
    • 14.3.7. Series Funding to Support Expansion of DNA Synthesis Technology
    • 14.3.8. NunaBio Raises GBP 1.9M In Seed Funding To Expand Infrastructure And Accelerate R&D
    • 14.3.9. Elegen Launches ENFINIA DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
    • 14.3.10. Ansa Biotechnologies Announces Successful de novo Synthesis of Oligonucleotide at 1005 Bases
    • 14.3.11. GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
    • 14.3.12. Evonetix Closes USD 24 million Financing
    • 14.3.13. Gene Synthesis (End-to-End) Now In India At Barcode Biosciences
    • 14.3.14. Eurofins Genomics Blue Heron launches IVT mRNA Synthesis Service: The Future of Gene Expression

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. GENE SYNTHESIS MARKET RESEARCH PROCESS
  • FIGURE 2. GENE SYNTHESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GENE SYNTHESIS MARKET DYNAMICS
  • FIGURE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 93. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 94. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 106. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 218. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 230. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 254. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 263. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 266. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 275. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 278. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 301. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 304. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 305. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 306. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 307. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 313. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 315. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 316. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 317. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 318. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 319. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 325. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 326. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 327. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 328. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 329. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 330. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 331. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 332. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 337. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 338. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 339. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 340. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 341. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 342. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 343. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 349. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 350. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 351. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 352. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 353. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 354. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 355. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 356. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 357. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 360. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 361. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 362. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 363. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 364. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 365. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 366. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
  • TABLE 367. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
  • TABLE 368. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
  • TABLE 369. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 370. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 371. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 372. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 373. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 374. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 375. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 376. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 377. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
  • TABLE 378. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2